Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

BioPhorum formed a group aimed at accelerating innovation across small molecule manufacturing

BioPhorum Unites 20 Organizations to Modernize Small Molecule Production

ByZachary Zubulake

July 1st 2026

Blood drop, floating stem cells. Hematopoietic stem cell collection, regenerative medicine, blood-derived stem cells, donor therapy, transplantation concept | Image Credit: ©Елена Бутусова -stock.adobe.com

FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients

BySusan Haigney

July 1st 2026

Roche Gets Priority Review for Enspryng; Announces Sequencing Platform

BySusan Haigney

June 30th 2026

Regulatory Developments Impacting Biologics

BySusan J. Schniepp,Siegfried Schmitt,Susan Haigney

June 30th 2026

Oxylanthanum carbonate was rejected for the 2nd time by the FDA

Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection

ByZachary Zubulake

June 30th 2026

March 2003

Articles in this issue

Related Content

BioPhorum Unites 20 Organizations to Modernize Small Molecule Production

FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients

Roche Gets Priority Review for Enspryng; Announces Sequencing Platform

Regulatory Developments Impacting Biologics

Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection

Trending on Pharmaceutical Technology

Roche Gets Priority Review for Enspryng; Announces Sequencing Platform

Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection

FDA Chooses 7 Companies for PreCheck Pilot

Regulatory Developments Impacting Biologics

Lonza Increases HPAPI Production at Visp Facility